Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure-Reference-Cited by-同舟云学术

Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure

Published:2017-09-01 Issue:9 Volume:2 Page:1025
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Packer Milton¹,Anker Stefan D.²,Butler Javed³,Filippatos Gerasimos⁴,Zannad Faiez⁵

Affiliation:

1. Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas

2. Department of Cardiology (CVK), Charité University Medicine, Berlin, Germany3Berlin-Brandenburg Center for Regenerative Therapies, Charité University Medicine, Berlin, Germany

3. Division of Cardiology, Stony Brook University, Stony Brook, New York

4. National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece

5. INSERM, Centre d’Investigations Cliniques 1433, Université de Lorraine, CHU de Nancy, Institut Lorrain du cœur et des vaisseaux, Nancy, France

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 293 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ARNI (Sacubitril/Valsartan) and SGLT2 Inhibitors (Dapagliflozin) either alone or in Combination on Heart Failure: An Exploration of Novelty;Journal of Young Pharmacists;2024-08-23

2. Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy;BMC Cardiovascular Disorders;2024-07-12

3. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature;Cureus;2024-07-04

4. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials;Journal of Cardiovascular Electrophysiology;2024-06-28

5. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions;International Journal of Molecular Sciences;2024-06-05